Hemodialysis patients are usually allowed to take Piperazine Ferulate. Piperazine ferulate is suitable for the adjuvant treatment of all kinds of glomerular diseases with microscopic hematuria and hypercoagulable state, such as nephritis, chronic nephritis, early stage of nephrotic syndrome, uremia, as well as coronary artery disease, cerebral infarction, vasculitis and so on. Therefore, for hemodialysis patients who are combined with the above diseases, it is also possible to take this product for adjuvant treatment. In addition, hemodialysis patients can not only take piperazine ferulate; can also use antihypertensive drugs, such as nifedipine extended-release tablets, valsartan, etc.; the use of phosphorus-binding agents, commonly used drugs such as calcium carbonate, lanthanum carbonate, sevelamer, etc.; the use of drugs to correct anemia, such as iron polysaccharides, erythropoietin, roxarestat, etc.. Piperazine ferulate has adverse reactions such as allergic reactions and gastrointestinal reactions. It is forbidden to combine with albendazole and bis(hydroxynaphthyl)thiopyrimidines. It is recommended that hemodialysis patients take the drug need to follow the doctor’s instructions, not self-administration, in order to avoid adverse effects.